Novo Nordisk, Spokesman Pay Extra Care to Regulatory Issues
NEW YORK (AdAge.com) — Scrutiny of direct-to-consumer advertising from the Food and Drug Administration may be heightening, but that has not deterred one pharmaceutical company from trying something new for the industry: a branded Twitter page.
FULL ARTICLE http://e.ccialerts.com/a/hBKXG$9AHJQfmAUDSLFASbv4uD0/clck63
General Mills No Longer Needs Huge Budgets to Talk to Specific Segments
CHICAGO (AdAge.com) — The package-goods model has always been a no-brainer: Create a mass-appeal product; distribute it nationally; stoke demand with big-budget, shotgun-style advertising to spray the widest possible market; and hope sales hit the magical $100 million first-year benchmark. But that traditional model is evolving at major marketers such as General Mills.
FULL ARTICLE http://e.ccialerts.com/a/hBKWx56AHJQfmAUDSLFASbv4ulI/clck15
Who’s Not Sick of Sexualized Sandwiches? Viral-Video Viewers
What People Watched the Week of June 22, 2009
by Abbey Klaassen
Published: July 02, 2009
NEW YORK (AdAge.com) — While Ad Age’s Ken Wheaton lamented the multitude of sex-fueled fast-food campaigns last week, apparently the broader viral-video-watching audience is not sick of the schtick. Carl’s Jr. snuck onto the Viral Video Chart this week in the No. 10 spot with its video of “The Hills” star Audrina Patridge eating a Teriyaki burger in a gold lame bikini. Carl’s Jr. is still on the chart (for the fourth week in a row) for a different campaign: Its “How to Eat a Portobello Mushroom Burger” video, which enlisted a number of YouTube stars, is in the No. 6 spot.
Tylenol Latest Big Brand to Come Under FDA Scrutiny
Panel Seeks to Limit Acetaminophen in OTC Medication; Drug Is Used in Many Marketers’ Products
Published: July 01, 2009
NEW YORK (AdAge.com) — First, the Food and Drug Administration went after Cheerios. Now it appears to be targeting another beloved U.S. brand: Tylenol.
The FDA advisory panel recommendation could present advertising problems for J&J and Tylenol, as well as the rest of the big players in the pain-relief industry.
An FDA advisory panel has recommended that the regulatory agency reduce the maximum dosage of acetaminophen, the main ingredient in over-the-counter pain relievers such as Johnson & Johnson’s Tylenol and Novartis’ Excedrin, to 325 milligrams a pill from 500 milligrams a pill, and to fewer than 4,000 total milligrams a day. It’s also recommending that the single 1,000-mg dose be available only by prescription. The same panel earlier had recommended pulling two prescription medications that contain acetaminophen, Percocet and Vicodin, off the market.